PRCT Insider Trading
Insider Ownership Percentage: 17.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $62,839,018.02
PROCEPT BioRobotics Insider Trading History Chart
This chart shows the insider buying and selling history at PROCEPT BioRobotics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
PROCEPT BioRobotics Share Price & Price History
Current Price: $53.03
Price Change: ▲ Price Increase of +0.22 (0.42%)
As of 04/17/2025 05:00 PM ET
PROCEPT BioRobotics Insider Trading History
PROCEPT BioRobotics Institutional Trading History
Data available starting January 2016
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Read More on PROCEPT BioRobotics
Today's Range
Now: $53.03
52 Week Range
Now: $53.03
Volume
868,416 shs
Average Volume
782,183 shs
Market Capitalization
$2.91 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.09
Who are the company insiders with the largest holdings of PROCEPT BioRobotics?
Who are the major institutional investors of PROCEPT BioRobotics?
Which major investors are selling PROCEPT BioRobotics stock?
During the previous quarter, PRCT stock was sold by these institutional investors:
- Enclave Advisors LLC
In the last year, company insiders that have sold PROCEPT BioRobotics company stock include:
- Frederic H Moll (Director)
- Antal Rohit Desai (Director)
- Reza Zadno (CEO)
- Morgan Colby Wood (Director)
- Kevin Waters (CFO)
- Hisham Shiblaq (EVP)
Learn More investors selling PROCEPT BioRobotics stock.
Which major investors are buying PROCEPT BioRobotics stock?
During the last quarter, PRCT stock was bought by institutional investors including:
- Chicago Capital LLC
- GAMMA Investing LLC
- Rhumbline Advisers
- Sentry Investment Management LLC
- Hennion & Walsh Asset Management Inc.